• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

FOGHORN THERAPEUTICS INC.

Notes

No. Proposition For Against Abstain
1

Election of Class III Director for a three-year term: Douglas Cole, M.D.

2

Election of Class III Director for a three-year term: Balkrishan (Simba) Gill, Ph.D.

3

Election of Class III Director for a three-year term: B. Lynne Parshall

4

To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026.

5

To approve, on an advisory basis, the compensation of Foghorns named executive officers.

6

To approve, on an advisory basis, the frequency of future advisory votes on the compensation of Foghorns named executive officers.